• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床实践中的哮喘-慢性阻塞性肺疾病重叠(ACO_CP 2023):迈向精准医学

Asthma-COPD Overlap in Clinical Practice (ACO_CP 2023): Toward Precision Medicine.

作者信息

Alsayed Ahmad R, Abu-Samak Mahmoud S, Alkhatib Mohammad

机构信息

Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman 11937, Jordan.

Department of Experimental Medicine, University of Rome "Tor Vergata", 00133 Roma, Italy.

出版信息

J Pers Med. 2023 Apr 18;13(4):677. doi: 10.3390/jpm13040677.

DOI:10.3390/jpm13040677
PMID:37109063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10146260/
Abstract

Asthma and COPD have characteristic symptoms, yet patients with both are prevalent. Despite this, there is currently no globally accepted definition for the overlap between asthma and COPD, commonly referred to as asthma-COPD overlap (ACO). Generally, ACO is not considered a distinct disease or symptom from either clinical or mechanistic perspectives. However, identifying patients who present with both conditions is crucial for guiding clinical therapy. Similar to asthma and COPD, ACO patients are heterogeneous and presumably have multiple underlying disease processes. The variability of ACO patients led to the establishment of multiple definitions describing the condition's essential clinical, physiological, and molecular characteristics. ACO comprises numerous phenotypes, which affects the optimal medication choice and can serve as a predictor of disease prognosis. Various phenotypes of ACO have been suggested based on host factors including but not limited to demographics, symptoms, spirometric findings, smoking history, and underlying airway inflammation. This review provides a comprehensive clinical guide for ACO patients to be used in clinical practice based on the available limited data. Future longitudinal studies must evaluate the stability of ACO phenotypes over time and explore their predictive powers to facilitate a more precise and effective management approach.

摘要

哮喘和慢性阻塞性肺疾病(COPD)有其特征性症状,但同时患有这两种疾病的患者也很常见。尽管如此,目前对于哮喘和COPD之间的重叠,即通常所说的哮喘-COPD重叠综合征(ACO),尚无全球公认的定义。一般来说,从临床或发病机制角度看,ACO都不被视为一种独特的疾病或症状。然而,识别同时患有这两种疾病的患者对于指导临床治疗至关重要。与哮喘和COPD类似,ACO患者具有异质性,可能存在多种潜在的疾病过程。ACO患者的变异性导致了多种描述该病症基本临床、生理和分子特征的定义的建立。ACO包含多种表型,这会影响最佳药物选择,并可作为疾病预后的预测指标。基于包括但不限于人口统计学、症状、肺功能检查结果、吸烟史和潜在气道炎症等宿主因素,已提出了ACO的各种表型。本综述基于现有的有限数据,为ACO患者提供了一份可用于临床实践的全面临床指南。未来的纵向研究必须评估ACO表型随时间的稳定性,并探索其预测能力,以促进更精确、有效的管理方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd69/10146260/0ff65ce142b6/jpm-13-00677-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd69/10146260/0ff65ce142b6/jpm-13-00677-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd69/10146260/0ff65ce142b6/jpm-13-00677-g001.jpg

相似文献

1
Asthma-COPD Overlap in Clinical Practice (ACO_CP 2023): Toward Precision Medicine.临床实践中的哮喘-慢性阻塞性肺疾病重叠(ACO_CP 2023):迈向精准医学
J Pers Med. 2023 Apr 18;13(4):677. doi: 10.3390/jpm13040677.
2
Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.气道阻塞患者中哮喘-COPD 重叠、哮喘和慢性阻塞性肺疾病表型的鉴定:对治疗方法的影响。
Respiration. 2020;99(1):35-42. doi: 10.1159/000503328. Epub 2019 Nov 6.
3
Practical Guide to the Identification and Diagnosis of Asthma-COPD Overlap (ACO).实用哮喘-慢性阻塞性肺疾病重叠(ACO)识别与诊断指南。
COPD. 2019 Feb;16(1):1-7. doi: 10.1080/15412555.2019.1575802. Epub 2019 Feb 21.
4
Current Knowledge of Asthma-COPD Overlap (ACO) Genetic Risk Factors, Characteristics, and Prognosis.哮喘-慢性阻塞性肺疾病重叠(ACO)遗传风险因素、特征和预后的最新认识。
COPD. 2021 Oct;18(5):585-595. doi: 10.1080/15412555.2021.1980870. Epub 2021 Sep 24.
5
Functional Predictors Discriminating Asthma-COPD Overlap (ACO) from Chronic Obstructive Pulmonary Disease (COPD).用于区分哮喘-慢性阻塞性肺疾病重叠(ACO)与慢性阻塞性肺疾病(COPD)的功能预测因子。
Int J Chron Obstruct Pulmon Dis. 2022 Oct 21;17:2723-2743. doi: 10.2147/COPD.S382761. eCollection 2022.
6
Asthma and COPD overlap pathophysiology of ACO.哮喘和 COPD 重叠的 ACO 病理生理学。
Allergol Int. 2018 Apr;67(2):179-186. doi: 10.1016/j.alit.2018.01.001. Epub 2018 Mar 15.
7
Asthma-COPD Overlap: What Are the Important Questions?哮喘-慢阻肺重叠:有哪些重要问题?
Chest. 2022 Feb;161(2):330-344. doi: 10.1016/j.chest.2021.09.036. Epub 2021 Oct 6.
8
Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma-COPD overlap.嗜酸粒细胞性气道疾病的疾病负担:比较严重哮喘、COPD 和哮喘-COPD 重叠。
Respirology. 2021 Jan;26(1):52-61. doi: 10.1111/resp.13841. Epub 2020 May 19.
9
Asthma COPD overlap: Insights into cellular and molecular mechanisms.哮喘-慢阻肺重叠:细胞和分子机制的新见解。
Mol Aspects Med. 2022 Jun;85:101021. doi: 10.1016/j.mam.2021.101021. Epub 2021 Sep 11.
10
Identification and definition of asthma-COPD overlap: The CanCOLD study.哮喘-慢性阻塞性肺疾病重叠的识别与定义:加拿大慢性阻塞性肺疾病队列研究
Respirology. 2020 Aug;25(8):836-849. doi: 10.1111/resp.13780. Epub 2020 Feb 16.

引用本文的文献

1
The Effect of Comorbidities on Asthma-Related Outcomes Over a Two-Year Period: A Prospective Analysis of Swiss Severe Asthma Registry (SSAR).合并症对两年期间哮喘相关结局的影响:瑞士重症哮喘登记处(SSAR)的前瞻性分析
J Asthma Allergy. 2025 Jul 15;18:1105-1118. doi: 10.2147/JAA.S521005. eCollection 2025.
2
Plasma Levels of CXCL9 and MCP-3 are Increased in Asthma-COPD Overlap (ACO) Patients.哮喘-慢性阻塞性肺疾病重叠综合征(ACO)患者血浆中CXCL9和MCP-3水平升高。
Int J Chron Obstruct Pulmon Dis. 2025 Apr 22;20:1161-1174. doi: 10.2147/COPD.S506517. eCollection 2025.
3
A Multifaceted Exploration of Status Asthmaticus: A Retrospective Analysis in a Romanian Hospital.

本文引用的文献

1
Alteration of the Respiratory Microbiome in Hospitalized Patients with Asthma-COPD Overlap during and after an Exacerbation.哮喘-慢性阻塞性肺疾病重叠综合征住院患者急性加重期及缓解期呼吸道微生物群的改变
J Clin Med. 2023 Mar 8;12(6):2118. doi: 10.3390/jcm12062118.
2
Molecular Accounting and Profiling of Human Respiratory Microbial Communities: Toward Precision Medicine by Targeting the Respiratory Microbiome for Disease Diagnosis and Treatment.人类呼吸道微生物群落的分子核算与剖析:通过靶向呼吸微生物组进行疾病诊断和治疗,实现精准医学。
Int J Mol Sci. 2023 Feb 17;24(4):4086. doi: 10.3390/ijms24044086.
3
GOLD COPD report: 2023 update.
重症哮喘的多方面探索:罗马尼亚一家医院的回顾性分析
J Clin Med. 2024 Nov 4;13(21):6615. doi: 10.3390/jcm13216615.
4
Fixed Airflow Obstruction in Asthma Can Be Identified Early by Low FEF25-75% and is Associated with Environmental Exposure.哮喘中的固定气流阻塞可通过低FEF25-75%早期识别,且与环境暴露有关。
J Asthma Allergy. 2024 Oct 11;17:1001-1014. doi: 10.2147/JAA.S479215. eCollection 2024.
5
Epidemiological characteristics of asthma-COPD overlap, its association with all-cause mortality, and the mediating role of depressive symptoms: evidence from NHANES 2005-2018.哮喘-COPD 重叠的流行病学特征、与全因死亡率的相关性,以及抑郁症状的中介作用:来自 NHANES 2005-2018 的证据。
BMC Public Health. 2024 May 28;24(1):1423. doi: 10.1186/s12889-024-18911-1.
6
Predicting parameters of airway dynamics generated from inspiratory and expiratory plethysmographic airway loops, differentiating subtypes of chronic obstructive diseases.从吸气和呼气容积描记气道环中预测气道动力学参数,区分慢性阻塞性疾病的亚型。
BMJ Open Respir Res. 2024 Mar 9;11(1):e002142. doi: 10.1136/bmjresp-2023-002142.
7
Assessment of functional diversities in patients with Asthma, COPD, Asthma-COPD overlap, and Cystic Fibrosis (CF).评估哮喘、COPD、哮喘-COPD 重叠和囊性纤维化(CF)患者的功能多样性。
PLoS One. 2024 Feb 20;19(2):e0292270. doi: 10.1371/journal.pone.0292270. eCollection 2024.
8
Knowledge and Practice of Healthcare Professionals in the Medical Care of Asthma Adult Patients in Jordan with a Particular Reference to Adherence to GINA Recommendations.约旦医疗保健专业人员在成年哮喘患者医疗护理方面的知识与实践,特别提及对全球哮喘防治创议(GINA)建议的依从性
J Multidiscip Healthc. 2024 Jan 26;17:391-404. doi: 10.2147/JMDH.S433149. eCollection 2024.
9
Personalized Medicine in Asthma: Current Approach and Future Perspectives.哮喘的个性化医疗:当前方法与未来展望
J Pers Med. 2023 Sep 30;13(10):1459. doi: 10.3390/jpm13101459.
10
COPD Patients with Asthma Features in Vietnam: Prevalence and Suitability for Personalized Medicine.越南具有哮喘特征的慢性阻塞性肺疾病患者:患病率及个性化医疗的适用性
J Pers Med. 2023 May 26;13(6):901. doi: 10.3390/jpm13060901.
慢性阻塞性肺疾病全球倡议(GOLD)报告:2023年更新版。
Lancet Respir Med. 2023 Jan;11(1):18. doi: 10.1016/S2213-2600(22)00494-5. Epub 2022 Nov 30.
4
A comprehensive clinical guide for pneumonia: a missing therapeutic target in HIV-uninfected patients.肺炎综合临床指南:HIV 阴性患者的治疗靶点缺失
Expert Rev Respir Med. 2022 Nov-Dec;16(11-12):1167-1190. doi: 10.1080/17476348.2022.2152332. Epub 2022 Dec 12.
5
Phenotypes of Asthma-Chronic Obstructive Pulmonary Disease Overlap.哮喘-慢性阻塞性肺疾病重叠的表型。
Immunol Allergy Clin North Am. 2022 Aug;42(3):645-655. doi: 10.1016/j.iac.2022.04.009. Epub 2022 Jun 30.
6
Investigating the human rhinovirus co-infection in patients with asthma exacerbations and COVID-19.调查哮喘急性加重患者和新冠肺炎患者中的人鼻病毒合并感染情况。
Pharm Pract (Granada). 2022 Apr-Jun;20(2):2665. doi: 10.18549/PharmPract.2022.2.2665. Epub 2022 May 2.
7
The first detection of Pneumocystis jirovecii in asthmatic patients post-COVID-19 in Jordan.约旦首例 COVID-19 后哮喘患者肺孢子菌的检测。
Bosn J Basic Med Sci. 2022 Sep 16;22(5):784-790. doi: 10.17305/bjbms.2022.7335.
8
Prognosis of Patients with Chronic Obstructive Pulmonary Disease Not Eligible for Major Clinical Trials.不符合主要临床试验条件的慢性阻塞性肺疾病患者的预后。
Am J Respir Crit Care Med. 2022 Aug 1;206(3):271-280. doi: 10.1164/rccm.202110-2441OC.
9
The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma-COPD Overlap Syndrome.重度哮喘患者对生物制剂的反应比对哮喘-慢性阻塞性肺疾病重叠综合征患者更好。
J Asthma Allergy. 2022 Mar 18;15:363-369. doi: 10.2147/JAA.S338467. eCollection 2022.
10
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.全球哮喘倡议 2021 策略:执行摘要和关键变更的理由。
Am J Respir Crit Care Med. 2022 Jan 1;205(1):17-35. doi: 10.1164/rccm.202109-2205PP.